Dr. Reddy’s Laboratories Limited (NYSE:RDY) today announced that its
Annual Report on Form 20-F, containing its annual consolidated financial
statements for the fiscal year ended 31 March, 2009 was filed with the
United States Securities and Exchange Commission on 6th July
2009.
The Annual Report on Form 20-F is also available on Dr. Reddy’s
corporate website, www.drreddys.com
and can be accessed by selecting ‘SEC filings’ under the ‘Investors’
Section. ADS holders may also obtain a hard copy of the Annual Report on
Form 20-F or Indian Annual Report, free of charge, by sending a written
request to the Company’s registered office or by sending an e-mail to shares@drreddys.com.
Disclaimer
This press release includes forward-looking statements, as defined in
the U.S. Private Securities Litigation Reform Act of 1995. We have based
these forward-looking statements on our current expectations and
projections about future events. Such statements involve known and
unknown risks, uncertainties and other factors that may cause actual
results to differ materially. Such factors include, but are not limited
to, changes in local and global economic conditions, our ability to
successfully implement our strategy, the market acceptance of and demand
for our products, our growth and expansion, technological change and our
exposure to market risks. By their nature, these expectations and
projections are only estimates and could be materially different from
actual results in the future.
About Dr. Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging
global pharmaceutical company. We fulfill our purpose of providing
affordable and innovative medicines through three core businesses:
Pharmaceutical Services and Active Ingredients, Global Generics and
Proprietary Products. Our products are marketed globally, with a focus
on India, US, UK, Germany and Russia.
www.drreddys.com
Dr. Reddy’s Laboratories Limited
Investors
and Financial Analysts:
Kedar Upadhye, +91-40-66834297
kedaru@drreddys.com
Raghavender
R, +91-40-66511529
raghavenderr@drreddys.com
Milan
Kalawadia, 908-203-4931 (USA)
mkalawadia@drreddys.com
Media:
M
Mythili, +91-40-66511620
mythilim@drreddys.com
S
Rajan, +91-40-66511725
rajans@drreddys.com